Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Sianglum, Wipawadee ^a   Srimanote, Potjanee ^b   Wonglumsom, Wijit ^c   Kittiniyom, Kanokwan ^c   Voravuthikunchai, Supayang P ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CELL PROTEIN; PLANT EXTRACT; RHODOMYRTONE; RHODOMYRTUS TOMENTOSA EXTRACT; UNCLASSIFIED DRUG; ALCOHOL; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; NEW DRUG; PROTEOME; VIRULENCE FACTOR; XANTHONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BIOSYNTHESIS; CELL DIVISION; CELL STRUCTURE; CELL WALL; CONTROLLED STUDY; CYTOLYSIS; MEDICINAL PLANT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT LEAF; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHODOMYRTUS TOMENTOSA; STAPHYLOCOCCUS AUREUS; ANTIBIOTIC RESISTANCE; CHEMISTRY; DRUG EFFECT; EVALUATION; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION; PHYSIOLOGY; TIME; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RHODOMYRTUS TOMENTOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; DRUGS, INVESTIGATIONAL; ETHANOL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, TRANSMISSION; PLANT EXTRACTS; PROTEOME; TIME FACTORS; VIRULENCE FACTORS; XANTHONES;

EID: 79951529993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016628     Document Type: Article

References (54)

1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771.
2. Cookson BD, (2000) Methicillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost? Infect Control Hosp Epidemiol 21: 398-403.
3. Zetola N, Francis JS, Nuermberger EL, Bishai WR, (2005) Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5: 275-286.
4. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, et al. (2003) Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348: 1342-1347.
5. Hiramatsu K, (2001) Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 1: 147-155.
6. Nguyen HM, Graber CJ, (2010) Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer? J Antimicrob Chemother 65: 24-36.
7. Manfredi R, Sabbatani S, (2010) Novel pharmaceutical molecules against emerging resistant gram-positive cocci. Braz J Infect Dis 14: 96-108.
8. Eliopoulos GM, (2009) Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria. J Infect 59 (Suppl 1): S17-24.
9. Martin KW, Ernst E, (2003) Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother 51: 241-246.
10. Tomczykowa M, Tomczyk M, Jakoniuk P, Tryniszewska E, (2008) Antimicrobial and antifungal activities of the extracts and essential oils of Bidens tripartita. Folia Histochem Cytobiol 46: 389-393.
11. Samy RP, Gopalakrishnakone P, (2008) Therapeutic Potential of Plants as Anti-microbials for Drug Discovery. Evid Based Complement Alternat Med pp. 283-294.
12. Dachriyanus S, Sargent MV, Skelton BW, Soediro I, Sutisna M, et al. (2002) Rhodomyrtone, an antibiotic from Rhodomyrtus tomentosa. Aust J Chem 55: 229-232.
13. Saising HA, Mahabusarakam W, Ongsakul M, Varavathikunchai SP, (2008) Rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. as a Natural Antibiotic for Staphylococcal Cutaneous Infections. J Health Sci 54: 589-595.
14. Limsuwan S, Voravuthikunchai SP, (2008) Boesenbergia pandurata (Roxb.) Schltr., Eleutherine americana Merr. and Rhodomyrtus tomentosa (Aiton) Hassk. as antibiofilm producing and antiquorum sensing in Streptococcus pyogenes. FEMS Immunol Med Microbiol 53: 429-436.
15. Limsuwan S, Trip EN, Kouwen TR, Piersma S, Hiranrat A, et al. (2009) Rhodomyrtone: a new candidate as natural antibacterial drug from Rhodomyrtus tomentosa. Phytomedicine 16: 645-651.
16. Cordwell SJ, Larsen MR, Cole RT, Walsh BJ, (2002) Comparative proteomics of Staphylococcus aureus and the response of methicillin-resistant and methicillin-sensitive strains to Triton X-100. Microbiology 148: 2765-2781.
17. Kohler C, Wolff S, Albrecht D, Fuchs S, Becher D, et al. (2005) Proteome analyses of Staphylococcus aureus in growing and non-growing cells: a physiological approach. Int J Med Microbiol 295: 547-565.
18. Scherl A, Francois P, Bento M, Deshusses JM, Charbonnier Y, et al. (2005) Correlation of proteomic and transcriptomic profiles of Staphylococcus aureus during the post-exponential phase of growth. J Microbiol Methods 60: 247-257.
19. Becker K, Bierbaum G, von Eiff C, Engelmann S, Gotz F, et al. (2007) Understanding the physiology and adaptation of staphylococci: a post-genomic approach. Int J Med Microbiol 297: 483-501.
20. Livermore DM, (2000) Antibiotic resistance in staphylococci. Int J Antimicrob Agents 16 (Suppl 1): S3-10.
21. Yu L, Xiang H, Fan J, Wang D, Yang F, et al. (2008) Global transcriptional response of Staphylococcus aureus to rhein, a natural plant product. J Biotechnol 135: 304-308.
22. Hadjivassileva T, Thurston DE, Taylor PW, (2005) Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria. J Antimicrob Chemother 56: 513-518.
23. Doyle M, Feuerbaum EA, Fox KR, Hinds J, Thurston DE, et al. (2009) Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer. J Antimicrob Chemother 64: 949-959.
24. Weber J, Senior AE, (1997) Catalytic mechanism of F1-ATPase. Biochim Biophys Acta 1319: 19-58.
25. Ly A, Henderson J, Lu A, Culham DE, Wood JM, (2004) Osmoregulatory systems of Escherichia coli: identification of betaine-carnitine-choline transporter family member BetU and distributions of betU and trkG among pathogenic and nonpathogenic isolates. J Bacteriol 186: 296-306.
26. Jarrige AC, Mathy N, Portier C, (2001) PNPase autocontrols its expression by degrading a double-stranded structure in the pnp mRNA leader. EMBO J 20: 6845-6855.
27. Gualerzi CO, Giuliodori AM, Pon CL, (2003) Transcriptional and post-transcriptional control of cold-shock genes. J Mol Biol 331: 527-539.
28. Sohlberg B, Huang J, Cohen SN, (2003) The Streptomyces coelicolor polynucleotide phosphorylase homologue, and not the putative poly(A) polymerase, can polyadenylate RNA. J Bacteriol 185: 7273-7278.
29. Foti JJ, Schienda J, Sutera VA Jr, Lovett ST, (2005) A bacterial G protein-mediated response to replication arrest. Mol Cell 17: 549-560.
30. Brunskill EW, de Jonge BL, Bayles KW, (1997) The Staphylococcus aureus scdA gene: a novel locus that affects cell division and morphogenesis. Microbiology 143 (Pt 9): 2877-2882.
31. Bramhill D, (1997) Bacterial cell division. Annu Rev Cell Dev Biol 13: 395-424.
32. Sugai M, Yamada S, Nakashima S, Komatsuzawa H, Matsumoto A, et al. (1997) Localized perforation of the cell wall by a major autolysin: atl gene products and the onset of penicillin-induced lysis of Staphylococcus aureus. J Bacteriol 179: 2958-2962.
33. Schleifer KH, Kandler O, (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36: 407-477.
34. Giesbrecht P, Kersten T, Maidhof H, Wecke J, (1998) Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol Mol Biol Rev 62: 1371-1414.
35. van den Ent F, Amos L, Lowe J, (2001) Bacterial ancestry of actin and tubulin. Curr Opin Microbiol 4: 634-638.
36. Scheffers DJ, Pinho MG, (2005) Bacterial cell wall synthesis: new insights from localization studies. Microbiol Mol Biol Rev 69: 585-607.
37. de Jonge BL, Chang YS, Gage D, Tomasz A, (1992) Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A. J Biol Chem 267: 11248-11254.
38. Maidhof H, Reinicke B, Blumel P, Berger-Bachi B, Labischinski H, (1991) femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. J Bacteriol 173: 3507-3513.
39. Gustafson JE, Berger-Bachi B, Strassle A, Wilkinson BJ, (1992) Autolysis of methicillin-resistant and-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 36: 566-572.
40. Singh VK, Utaida S, Jackson LS, Jayaswal RK, Wilkinson BJ, et al. (2007) Role for dnaK locus in tolerance of multiple stresses in Staphylococcus aureus. Microbiology 153: 3162-3173.
41. Squires C, Squires CL, (1992) The Clp proteins: proteolysis regulators or molecular chaperones? J Bacteriol 174: 1081-1085.
42. Jenal U, Fuchs T, (1998) An essential protease involved in bacterial cell-cycle control. EMBO J 17: 5658-5669.
43. Turgay K, Hahn J, Burghoorn J, Dubnau D, (1998) Competence in Bacillus subtilis is controlled by regulated proteolysis of a transcription factor. EMBO J 17: 6730-6738.
44. Weichart D, Querfurth N, Dreger M, Hengge-Aronis R, (2003) Global role for ClpP-containing proteases in stationary-phase adaptation of Escherichia coli. J Bacteriol 185: 115-125.
45. Squires CL, Pedersen S, Ross BM, Squires C, (1991) ClpB is the Escherichia coli heat shock protein F84.1. J Bacteriol 173: 4254-4262.
46. Thomas JG, Baneyx F, (2000) ClpB and HtpG facilitate de novo protein folding in stressed Escherichia coli cells. Mol Microbiol 36: 1360-1370.
47. Lorenz U, Ohlsen K, Karch H, Hecker M, Thiede A, et al. (2000) Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus. FEMS Immunol Med Microbiol 29: 145-153.
48. Nishino T, (1975) An electron microscopic study of antagonism between cephalexin and erythromycin in Staphylococcus aureus. Jpn J Microbiol 19: 53-63.
49. Belley A, Harris R, Beveridge T, Parr T Jr, Moeck G, (2009) Ultrastructural effects of oritavancin on methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Antimicrob Agents Chemother 53: 800-804.
50. Giesbrecht P, Wecke J, Reinicke B, (1976) On the morphogenesis of the cell wall of staphylococci. Int Rev Cytol 44: 225-318.
51. Hiranrat A, Mahabusarakam W, (2008) New acylphloroglucinols from the leaves of Rhodomyrtus tomentosa. Tetrahedron 64: 11193-11197.
52. Chusri S, Voravuthikunchai SP, (2009) Detailed studies on Quercus infectoria Olivier (nutgalls) as an alternative treatment for methicillin-resistant Staphylococcus aureus infections. J Appl Microbiol 106: 89-96.
53. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing: Fifteenth Informational Supplement. M100-S15. Wayne, PA CLSI.
54. Towbin H, Staehelin T, Gordon J, (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76: 4350-4354.